Author

C. Y.-L. Chung

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. Yoshioka· 1 shared H. Jimbo· 1 shared H. Tanizawa· 1 shared K.-i. Noma· 1 shared S. Hashimoto· 1 shared S. Ohta· 1 shared T. Fukumoto· 1 shared X. Wang· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Yoshioka

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivOct 19, 2023

Chemo-senolytic therapeutic potential against angiosarcoma

X. Wang, C. Y.-L. Chung, A. Yoshioka…·K.-i. Noma

This study explores combining cisplatin and the senolytic agent ABT-263 to treat angiosarcoma, showing that low-dose cisplatin induces senescence, which is then eliminated by ABT-263, reducing chemotherapy side effects.

DOI 10.1016/j.jid.2024.03.026

humanexperimental assay

𝕏 PostBluesky